Huntington' disease - Imbalance of amino acid levels in plasma of patients and mutation carriers

Annals of Agricultural and Environmental Medicine

Volumn 20, Issue 4, 2013, Pages 779-783

  Gruber, Beata M ^a   Kłaczkow, Gabriela ^a   Jaworska, Małgorzata ^a   Krzysztoń Russjan, Jolanta ^a   Anuszewska, Elzbieta L ^a   Zielonka, Daniel ^b   Klimberg, Aneta ^b   Marcinkowski, Jerzy T ^b  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Amino acids; Biochemical analysis; Biomarkers; HPLC; Huntington's disease; Plasma analysis

Indexed keywords

AMINO ACID; ARGININE; ASPARAGINE; C REACTIVE PROTEIN; CITRULLINE; CREATININE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; HISTIDINE; HYDROCORTISONE; LEUCINE; LYSINE; METHIONINE; ORNITHINE; PROLINE; SERINE; THREONINE; THYROTROPIN; UREA; VALINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CAG REPEAT; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE; GENE MUTATION; HTT GENE; HUMAN; HUNTINGTON CHOREA; MALE; MIDDLE AGED; PROTEIN METABOLISM;

ADULT; AMINO ACIDS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; MUTATION;

EID: 84891052207     PISSN: 12321966     EISSN: 18982263     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mochel F, Charles P, Seguin F, Barritault J, Coussieu Ch, Perin L et al. Early energy deficit in Huntington disease: Identification of a plasma biomarker traceable during disease progression. PLoS ONE 2007; 2: e647. doi: 10. 1371/journal. pone. 0000647.
2. Handley O J, van Walsem M, Juni P, Bachoud-Levi A-C, Bentivoglio AR, Bonelli RM, et al. Study Protocol of Registry-version 2. 0-European Huntington's Disease Network (EHDN). Hygeia Public Health 2011; 46: 115-182.
3. Jaworska M, Stańczyk M, Kłaczkow G, Wilk M, Anuszewska E, Barzał J, et al. New approach for amino acid profiling in human plasma by selective fluorescence derivatization. Amino Acids 2012; 43(4): 1653-1661.
4. Le Boucher J, Charret C, Coudray-Lucas C, Giboudeau J, Cynober L. Amino acid determination in biological fluids by automated ionexchange chromatography: performance of Hitachi L-8500A. Clin Chem. 1997; 43: 1421-1428.
5. van der Burg JMM, Bacos K, Wood NI, Lidquist A, Wierup N, Woodman B et al. Increased metabolism in the R6/2 mouse model of Huntington's disease. Neurobiol Dis. 2008; 29: 41-51.
6. Weir DW, Sturrock A, Leavitt BR. Development of biomarkers for Huntington's disease. Lancet Neurol. 2011; 10: 573-590.
7. Stoy N, Mackay GM, Forrest CM, Christofides J, Egerton M, Stone TW, et al. Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J Neurochem. 2005; 93: 611-623.
8. Mochel F, Benaich S, Rabier D, Durr A. Validation of plasma branched chain amino acids as biomarkers in Huntington disease. Arch Neurol. 2011; 68: 265-267.
9. Reilmann R, Rolf LH, Lange HW. Decreased plasma alanine and isoleucine in Huntington's disease. Acta Neurol Scand. 1995; 91: 222-224.
10. Kuiper MA, Teerlink T, Visser JJ, Bergmans PL, Scheltens P, Wolters EC. L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients. J Neural Transm. 2000; 107: 183-189.
11. Oepen G, Cramer H, Bernasconi R, Martin P. Huntington's disease-imbalance of free amino acids in the cerebrospinal fluid of patients and offspring at-risk. Arch Psychiat Nervenkrankh. 1982; 231: 131-140.
12. Moffett JR, Ross B, Arun P, Madhavarao ChN, Namboodiri AMA. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol. 2007; 81: 89-131.
13. Jenkins BG, Klivenyi P, Kustermann E, Andreassen OA, Ferrante RJ, Rosen BR et al. Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. J Neurochem. 2000; 74: 2108-2019.
14. Shimizu T, Matsuoka Y, Shirasawa T. Biological significance of isoaspartate and its repair system. Biol Pharm Bull. 2005; 28: 1590-1596.
15. Yamamoto T, Nishizaki I, Furuya S, Hirabayashi Y, Takahashi K, Okuyama S et al. Characterization of rapid and high-affinity uptake of L-serine in neurons and astrocytes in primary culture. FEBS Lett. 2003;. 548: 69-73.
16. Castagne V, Maire J-C, Moennoz D, Gyger M. Effect of threonine on the behavioural development of the rat. Pharmacol Biochem Be. 1995; 52: 281-289.
17. Sakagami H, Satoh M, Yokote Y, Takano H, Takahama M, Kochi M et al. Amino acid utilization during cell growth and apoptosis induction. Anticancer Res. 1998; 18: 4303-4306.